Close of Accelerated Bookbuild

RNS Number : 6239N

Futura Medical PLC

27 October 2016

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF IRELAND OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO.

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT ITSELF CONSTITUTE AN OFFER FOR SALE OR SUBSCRIPTION OF ANY SECURITIES IN THE COMPANY.  THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES OF FUTURA MEDICAL PLC IN ANY JURISDICTION IN WHICH ANY SUCH OFFER OR SOLICITATION WOULD BE UNLAWFUL.  NEITHER THIS ANNOUNCEMENT NOR THE FACT OF ITS DISTRIBUTION, SHALL FORM THE BASIS OF, OR BE RELIED ON IN CONNECTION WITH ANY INVESTMENT DECISION IN RESPECT OF FUTURA MEDICAL PLC.

27 October 2016

This announcement contains inside information

Futura Medical plc

("Futura" or the "Company")

Close of accelerated bookbuild - successful fundraise of £12 million at 57p per share

Futura Medical plc (AIM: FUM) announces that, further to the announcement made earlier today entitled "Proposed accelerated bookbuild to raise up to circa £12 million at 57 pence per share", the accelerated bookbuild process has now closed.

The accelerated bookbuild has been successful and the Company has conditionally raised a total of £12 million in gross proceeds via this Placing, which remains subject to the passing of certain resolutions by the shareholders of the Company at a General Meeting. As previously indicated, a circular will be posted shortly giving Shareholders details of the Placing and giving notice of the General Meeting.

The Company will shortly announce the full details of the proposed Placing including the final number of shares to be issued pursuant to the Placing. 

For further information please contact:

Futura Medical plc
James Barder, Chief Executive		Tel: [phone]
Email to: [e-mail]		www.futuramedical.com
N+1 Singer (Nominated Adviser and Broker)
Aubrey Powell / Liz Yong		Tel:[phone]
For media enquiries please contact:
Buchanan
Mark Court / Sophie Cowles / Stephanie Watson		Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

END

 

 

MSCPGGQCUUPQURM